Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension
The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Animal studies have shown that oxidative stress and renal tubulointerstitial inflammation are associated with, and have major roles in, the pathogenesis of hypertension. This view is supported by the observations that alleviation of oxidative stress and renal tubulointerstitial inflammation reduce arterial pressure in animal models. Conversely, hypertension has been shown to cause oxidative stress and inflammation in renal and cardiovascular tissues in experimental animals. Taken together, these observations indicate that oxidative stress, inflammation and arterial hypertension participate in a self-perpetuating cycle which, if not interrupted, can lead to progressive cardiovascular disease and renal complications. These events usually occur in an insidious and asymptomatic manner over an extended period following the onset of hypertension. Severe target organ injury can, however, occasionally occur precipitously in the course of malignant or accelerated hypertension. Given the high degree of heterogeneity of hypertensive disorders, the factor(s) initiating the vicious cycle described vary considerably in different forms of hypertension. For instance, oxidative stress in the kidney and vascular tissue is the primary mediator in the pathogenesis of angiotensin-induced, and perhaps lead-induced, hypertension. By contrast, increased arterial pressure is probably the initiating trigger in salt-sensitive hypertension. Although the initiating factor might vary between hypertensive disorders, according to the proposed model, the three components of the cycle eventually coalesce in all forms of hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there have been some successes (e.g. [1633]), the results have generally been decidedly mixed, with little clinical benefit (or even actual disbenefit) following from their administration [692,1588,1634-1639]”
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Antioxidant and redox regulation of gene transcription
Sen, C. K., & Packer, L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635688 · Cited by 1,981 · cited 1×
“NFκB serves as the general transcription factor for several pro-inflammatory cytokines, chemokines and adhesion molecules, and is activated by micromolar concentrations of H 2 O 2”
BackgroundVitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Research works printed but not linked: 3
- Nava M et al. (2003) Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284: F447–F454 · DOI
- Beswick RA et al. (2001) Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781–786 · DOI · Paper page
- Rodríguez-Iturbe B et al. (2003) Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341–346 · DOI · Paper page
Cited by
Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?
Biswas, S. K. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5698931 · Cited by 1,166
“Conversely, if inflammation is the primary event, oxidative stress will develop as a consequence which will further exaggerate inflammation [69].”
BackgroundDiabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
“Conversely, if inflammation is the main event, oxidative stress will develop as a consequence which will further exaggerate the inflammation [68].”
BackgroundNADPH Oxidases, Reactive Oxygen Species, and Hypertension
Paravicini, T. M., & Touyz, R. M. (2008) · Diabetes Care · doi:10.2337/dc08-s247 · Cited by 724
Ruiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013) · Kidney International · doi:10.1038/ki.2012.439 · Cited by 718
Self-citationOxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
“It is well established that Ang II increases oxidative and inflammation, factors that are critically associated with renal pathogenesis, particularly due to hypertension and diabetes (258,306).”
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“and may be mediated mainly via ROSs [692].”
BackgroundOhta, S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.04.006 · Cited by 514
Holt, E. M., Steffen, L. M., Moran, A., Basu, S., Steinberger, J., Ross, J. A., Hong, C.-P., & Sinaiko, A. R. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.11.036 · Cited by 496
Reactive oxygen species and vascular biology: implications in human hypertension
Touyz, R. M., & Briones, A. M. (2011) · Hypertension Research · doi:10.1038/hr.2010.201 · Cited by 470
Boskabady, M., Marefati, N., Farkhondeh, T., Shakeri, F., Farshbaf, A., & Boskabady, M. H. (2018) · Environment International · doi:10.1016/j.envint.2018.08.013 · Cited by 451
Oxidative Stress and Hypertension
Harrison, D. G., & Gongora, M. C. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.015 · Cited by 445
Vitamin C: Update on physiology and pharmacology
Mandl, J., Szarka, A., & Bánhegyi, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00282.x · Cited by 451
Mechanisms of lead-induced hypertension and cardiovascular disease
Vaziri, N. D. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00158.2008 · Cited by 441
Self-citationRole of the Immune System in Hypertension
Rodriguez-Iturbe, B., Pons, H., & Johnson, R. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2016 · Cited by 391
Self-citationShen, Y., Wang, X., Lu, J., Salfenmoser, M., Wirsik, N. M., Schleussner, N., Imle, A., Freire Valls, A., Radhakrishnan, P., Liang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.005 · Cited by 339
Ohta, S. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797052664 · Cited by 296
“Acute oxidative stress arises from various different situations: inflammation, cardiac or cerebral infarction, organ transplantation, heavy exercise, cessation of operative bleeding, and others [2, 34, 35].”
BackgroundMeli, R., Monnolo, A., Annunziata, C., Pirozzi, C., & Ferrante, M. C. (2020) · Antioxidants · doi:10.3390/antiox9050405 · Cited by 288
“Many other redox-sensitive signal transduction pathways like c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase and transcription factor AP-1 also participate and sustain the vicious cycle between inflammation and oxidative stress [29].”
BackgroundTherapeutic Potential of Quercetin to Decrease Blood Pressure: Review of Efficacy and Mechanisms
Larson, A. J., Symons, J. D., & Jalili, T. (2012) · Advances in Nutrition · doi:10.3945/an.111.001271 · Cited by 294
The biology of ergothioneine, an antioxidant nutraceutical
Borodina, I., Kenny, L. C., McCarthy, C. M., Paramasivan, K., Pretorius, E., Roberts, T. J., van der Hoek, S. A., & Kell, D. B. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422419000301 · Cited by 296
Montezano, A. C., & Touyz, R. M. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5302 · Cited by 270
Carlström, M., Persson, A. E. G., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., Weitzberg, E., & Lundberg, J. O. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq366 · Cited by 261
“Overall, it is believed that any condition that leads to an increase in ROS production and/or a decrease in NO generation shifts the balance towards oxidative stress and influences renal and vascular function, contributing to the pathophysiology of salt sensitivity.(10,11) Thus, interventions aimed at increasing NO bi…”
BackgroundJohnson, S. A., Figueroa, A., Navaei, N., Wong, A., Kalfon, R., Ormsbee, L. T., Feresin, R. G., Elam, M. L., Hooshmand, S., Payton, M. E., et al. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.11.001 · Cited by 248
Han, J., Pan, X.-Y., Xu, Y., Xiao, Y., An, Y., Tie, L., Pan, Y., & Li, X.-J. (2012) · Autophagy · doi:10.4161/auto.19471 · Cited by 253
Hypertension and physical exercise: The role of oxidative stress
Korsager Larsen, M., & Matchkov, V. V. (2016) · Medicina · doi:10.1016/j.medici.2016.01.005 · Cited by 222
Molecular Hydrogen as a Novel Antioxidant
Ohta, S. (2015) · Methods in Enzymology · doi:10.1016/bs.mie.2014.11.038 · Cited by 219
Touyz, R. M. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1302 · Cited by 222
Molecular hydrogen: a preventive and therapeutic medical gas for various diseases
Ge, L., Yang, M., Yang, N.-N., Yin, X.-X., & Song, W.-G. (2017) · Oncotarget · doi:10.18632/oncotarget.21130 · Cited by 216
Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration
Casals, E., Zeng, M., Parra‐Robert, M., Fernández‐Varo, G., Morales‐Ruiz, M., Jiménez, W., Puntes, V., & Casals, G. (2020) · Small · doi:10.1002/smll.201907322 · Cited by 204
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Oxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies
Montezano, A. C., & Touyz, R. M. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.653393 · Cited by 193
Oxidative Stress and Hypertensive Diseases
Loperena, R., & Harrison, D. G. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.004 · Cited by 189
Air pollution and circulating biomarkers of oxidative stress
Delfino, R. J., Staimer, N., & Vaziri, N. D. (2011) · Air Quality, Atmosphere & Health · doi:10.1007/s11869-010-0095-2 · Cited by 181
“2000), hypertension (Vaziri and Rodríguez-Iturbe 2006), and chronic kidney disease (Vaziri 2004).”
BackgroundSelf-citationIntermittent Hypoxia: Cause of or Therapy for Systemic Hypertension?
Serebrovskaya, T. V., Manukhina, E. B., Smith, M. L., Downey, H. F., & Mallet, R. T. (2008) · Experimental Biology and Medicine · doi:10.3181/0710-mr-267 · Cited by 168
Klein, M. L., Francis, P. J., Rosner, B., Reynolds, R., Hamon, S. C., Schultz, D. W., Ott, J., & Seddon, J. M. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.01.036 · Cited by 172
Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction
Didion, S. P., Kinzenbaw, D. A., Schrader, L. I., Chu, Y., & Faraci, F. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.137158 · Cited by 162
Kraynak, T. E., Marsland, A. L., Wager, T. D., & Gianaros, P. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.013 · Cited by 165
“It is well established, for example, that inflammatory processes in the periphery are involved in the pathogenesis of coronary artery disease (Libby et al., 2002), hypertension (Vaziri and Rodríguez-Iturbe, 2006), and the metabolic syndrome (Hotamisligil, 2006).”
The Effects of Hyperbaric Oxygenation on Oxidative Stress, Inflammation and Angiogenesis
de Wolde, S. D., Hulskes, R. H., Weenink, R. P., Hollmann, M. W., & van Hulst, R. A. (2021) · Biomolecules · doi:10.3390/biom11081210 · Cited by 199
Tapia, E., Soto, V., Ortiz-Vega, K. M., Zarco-Márquez, G., Molina-Jijón, E., Cristóbal-García, M., Santamaría, J., García-Niño, W. R., Correa, F., Zazueta, C., et al. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/269039 · Cited by 159
Atanur, S. S., Diaz, A. G., Maratou, K., Sarkis, A., Rotival, M., Game, L., Tschannen, M. R., Kaisaki, P. J., Otto, G. W., Ma, M. C. J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.040 · Cited by 161
Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum
Bisson, C. M., Dautel, S. E., Patel, E., Suresh, S. C., Dauer, P., & Rana, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1144170 · Cited by 166
“The complex interplay between placental pathology, inflammation, and changes in angiogenesis ultimately results in the clinical syndrome known as preeclampsia and contributes to adverse health outcomes in patients during pregnancy and postpartum (28, 29).”
BackgroundChoghakhori, R., Abbasnezhad, A., Hasanvand, A., & Amani, R. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.005 · Cited by 171
“Immune cells activation and infiltration, can produce the ROS by resident cells [11].”
Racial Differences in Oxidative Stress and Inflammation: In Vitro and In Vivo
Feairheller, D. L., Park, J., Sturgeon, K. M., Williamson, S. T., Diaz, K. M., Veerabhadrappa, P., & Brown, M. D. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00264.x · Cited by 148
Oxidative stress-induced diseases and tea polyphenols
Mao, X., Gu, C., Chen, D., Yu, B., & He, J. (2017) · Oncotarget · doi:10.18632/oncotarget.20887 · Cited by 142
“These also demonstrate that oxidative stress and inflammation are closely related pathophysiological processes, and both are stimultaneously found in many pathological conditions [39, 57, 58].”
BackgroundVaziri, N. D., Bai, Y., Ni, Z., Quiroz, Y., Pandian, R., & Rodríguez‐Iturbe, B. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123638 · Cited by 145
Self-citationCho, K.-H., Kim, H.-J., Rodriguez-Iturbe, B., & Vaziri, N. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00126.2009 · Cited by 144
Self-citationSantos, C. X. C., Nabeebaccus, A. A., Shah, A. M., Camargo, L. L., Filho, S. V., & Lopes, L. R. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5262 · Cited by 140
“Factors implicated in the pathophysiology of hypertension include activation of the sympathetic nervous system, up-regulation of the renin-angiotensin-aldosterone system, altered G protein-coupled receptor signaling, and inflammation (36, 105).”
Causal link between oxidative stress, inflammation, and hypertension.
Vaziri, N. D. (2008) · Iranian Journal of Kidney Diseases · Cited by 170
Self-citationOxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts
Djamali, A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00037.2007 · Cited by 129
“OS can also contribute to tubular atrophy through apoptosis (6, 10, 24, 101) and inflammation (19, 56, 58, 100).”
BackgroundVong, L. B., Bui, T. Q., Tomita, T., Sakamoto, H., Hiramatsu, Y., & Nagasaki, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.023 · Cited by 132
From Hypertension to Stroke: Mechanisms and Potential Prevention Strategies
Yu, J., Rui-rui, Z. H. O. U., & Cai, G. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00264.x · Cited by 145
“There is compelling evidence that oxidative stress play a critical part in the pathogenesis of hypertension, and stroke as a long-term complication [42,43].”
BackgroundHomayouni, F., Haidari, F., Hedayati, M., Zakerkish, M., & Angali, K. A. (2018) · Phytotherapy Research · doi:10.1002/ptr.6046 · Cited by 126
“There is a strong causal association between hypertension, inflammation, and oxidative stress (Vaziri & Rodriguez‐Iturbe, 2006), the potential antihypertensive, anti‐inflammatory, and antioxidant properties of hesperidin may in turn help in the interpretation of the obtained results in this study.”
BackgroundSim, M., Kim, C.-S., Shon, W.-J., Lee, Y.-K., Choi, E. Y., & Shin, D.-M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68930-2 · Cited by 129
Hughson, M. D., Gobe, G. C., Hoy, W. E., Manning, R. D., Douglas-Denton, R. N., & Bertram, J. F. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.023 · Cited by 126
Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?
Barrows, I. R., Ramezani, A., & Raj, D. S. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.03.001 · Cited by 127
“[18] They regulates endothelial function and vascular tone and vascular remodeling through proliferation and apoptosis.[96] Chronic inflammation is known to promote oxidative stress and vice versa by activating transcription factors such as nuclear factor (NF)-κB.”
BackgroundBravo, Y., Quiroz, Y., Ferrebuz, A., Vaziri, N. D., & Rodríguez-Iturbe, B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00507.2006 · Cited by 115
“We believe that these phenomena, supporting one another, may represent the final common pathway in the pathogenesis of salt-driven increments in blood pressure (43, 48, 62) and hypothesized that tubulointerstitial infiltration of immune-competent cells was a major player in the pathogenesis of hypertension associated…”
BackgroundSelf-citationBoeno, F. P., Ramis, T. R., Munhoz, S. V., Farinha, J. B., Moritz, C. E. J., Leal-Menezes, R., Ribeiro, J. L., Christou, D. D., & Reischak-Oliveira, Á. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002581 · Cited by 126
“In established systemic AH, proinflammatory cytokines and chemokines are released, including TNF-a, C-reactive protein (CRP) and monocyte chemoattractant protein-1 (MCP-1) and are associated with decreased expression and activity of endothelial nitric oxide synthase, oxidative stress and reduced nitric oxide (NO) bioa…”
BackgroundThe role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease
Rabkin, S. W. (2009) · Nature Reviews Cardiology · doi:10.1038/ncpcardio1453 · Cited by 113
“dtd" [ ]> Introduction Growing evidence indicates that inflammation is involved in many chronic diseases, such as hypertension”
Mercury and metabolic syndrome: a review of experimental and clinical observations
Tinkov, A. A., Ajsuvakova, O. P., Геннадиевна, С. М., Popova, E. V., Синицкий, А. И., Немерешина, О. Н., Gatiatulina, E. R., Nikonorov, A. А., & Skalny, A. V. (2015) · BioMetals · doi:10.1007/s10534-015-9823-2 · Cited by 114
Adiponectin: an adipokine with protective features against metabolic syndrome.
Esfahani, M., Movahedian, A., Baranchi, M., & Goodarzi, M. T. (2015) · PubMed Central · Cited by 152
The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity
Zhou, Y., Li, H., & Xia, N. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.650214 · Cited by 137
“The accumulated ROS cause cellular dysfunction and tissue damage by direct oxidative modification of biomolecules, and modulate redox-sensitive signal transduction pathways and transcription factors (14).”
BackgroundStress, Oxidative Injury and Disease
Srivastava, K. K., & Kumar, R. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0441-5 · Cited by 125
Vo, T. T. T., Chu, P., Tuan, V. P., Te, J. S.-L., & Lee, I. (2020) · Antioxidants · doi:10.3390/antiox9121211 · Cited by 124
New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials
Shi, H., Huang, Z., Xu, T., Sun, A., & Ge, J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103968 · Cited by 115
Vaziri, N. D., & Khan, A. H. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04644.x · Cited by 114
Self-citationFranco, M., Martínez-Morales, F., Quiroz, Y., Galicia-Cruz, O. G., Bautista, R., Johnson, R. J., & Rodríguez‐Iturbe, B. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00645.2006 · Cited by 107
“Among these conditions, a critical role is likely played by oxidative stress that is known to be inextricably associated with both local inflammation and blood pressure (17, 26).”
BackgroundSelf-citationUltrasmall Antioxidant Cerium Oxide Nanoparticles for Regulation of Acute Inflammation
Kim, J., Hong, G., Mazaleuskaya, L., Hsu, J. C., Rosario‐Berríos, D. N., Großer, T., Cho-Park, P. F., & Cormode, D. P. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c16126 · Cited by 106
Oxidative Stress in Kidney Injury and Hypertension
Arendshorst, W. J., Vendrov, A. E., Kumar, N., Ganesh, S. K., & Madamanchi, N. R. (2024) · Antioxidants · doi:10.3390/antiox13121454 · Cited by 124
Antioxidant approaches for the treatment of Alzheimer’s disease
Lee, H. P., Zhu, X., Casadesus, G., Castellani, R. J., Nunomura, A., Smith, M. A., Lee, H.-G., & Perry, G. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.74 · Cited by 105
Pons, H., Ferrebuz, A., Quiroz, Y., Romero-Vásquez, F., Parra, G., Johnson, R. J., & Rodríguez‐Iturbe, B. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00517.2012 · Cited by 104
“Renal inflammation is inevitably accompanied by intrarenal oxidative stress and increased local angiotensin II activity (5, 34, 36) that induce renal vasoconstriction, reduce the peritubular capillary network and impair pressure natriuresis (8, 14, 22).”
BackgroundSelf-citationJavkhedkar, A. A., Quiroz, Y., Rodriguez-Iturbe, B., Vaziri, N. D., Lokhandwala, M. F., & Banday, A. A. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00308.2014 · Cited by 100
Self-citationCitrulline: pharmacological perspectives and its role as an emerging biomarker in future
Kaore, S. N., Amane, H. S., & Kaore, N. M. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01059.x · Cited by 105
The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side
Togliatto, G., Lombardo, G., & Brizzi, M. F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091988 · Cited by 104
“In fact, a variety of molecules that belong to the “ROS group” and have different effects on cellular function are involved in the molecular events that control blood pressure [7,32,33].”
Nakayama, M., Nakano, H., Hamada, H., Itami, N., Nakazawa, R., & Ito, S. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq196 · Cited by 96
He, W., Wang, C., Chen, Y., He, Y., & Cai, Z. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.06.006 · Cited by 96
Bahadoran, Z., Golzarand, M., Mirmiran, P., Saadati, N., & Azizi, F. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12048 · Cited by 92
The Ubiquitin-Like Protein FAT10 Mediates NF-κB Activation
Gong, P., Canaan, A., Wang, B., Leventhal, J. S., Snyder, A., Nair, V., Cohen, C. D., Kretzler, M., D’Agati, V. D., Weissman, S. M., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050479 · Cited by 95
Jing, W., Vaziri, N. D., Nunes, A. C. F., Suematsu, Y., Farzaneh, T., Khazaeli, M., & Moradi, H. (2017) · PubMed Central · Cited by 91
Self-citationAlzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
Marlatt, M. W., Lucassen, P. J., Perry, G. L., Smith, M. A., & Zhu, X. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15206 · Cited by 97
“Although the initiating factors for hypertensive disorders may vary, oxidative stress and inflammation have major roles in the pathogenesis of hypertension, and these three conditions participate in a selfperpetuating cycle that can lead to progressive cardiovascular disease [102].”
de Faria, J. B. L., Silva, K. C., & de Faria, J. M. L. (2011) · Hypertension Research · doi:10.1038/hr.2010.263 · Cited by 95
The Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress
Emma, R., Caruso, M., Campagna, D., Pulvirenti, R., & Volti, G. L. (2022) · Antioxidants · doi:10.3390/antiox11091829 · Cited by 100
“In the presence of high levels of O2, NO is inactivated through the following reaction: NO + O2 → ONOO- [104].”
BackgroundArena, A., Zimmer, T. S., van Scheppingen, J., Korotkov, A., Anink, J. J., Mühlebner, A., Jansen, F. E., van Hecke, W., Spliet, W. G., van Rijen, P. C., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12661 · Cited by 89
“Various studies support the existence of a self-sustaining cycle between OS generation and brain inflammation (10,13,68).”
Zhang, R. M., McNerney, K. P., Riek, A. E., & Bernal‐Mizrachi, C. (2020) · Acta Physiologica · doi:10.1111/apha.13487 · Cited by 88
Pathophysiological Mechanisms of Salt-Dependent Hypertension
Rodríguez‐Iturbe, B., Romero, F., & Johnson, R. J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.025 · Cited by 88
Self-citationThe growth factor midkine regulates the renin-angiotensin system in mice
Hobo, A., Yuzawa, Y., Kosugi, T., Kato, N., Asai, N., Sato, W., Maruyama, S., Ito, Y., Kobori, H., Ikematsu, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37249 · Cited by 94
“CKD accompanies multiple organ failure, the pathogenesis of which involves inter-organ cross-talk (17, 18).”
BackgroundInfluentialYang, T., Peleli, M., Zollbrecht, C., Giulietti, A., Terrando, N., Lundberg, J. O., Weitzberg, E., & Carlström, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.016 · Cited by 91
Koeners, M. P., van Faassen, E. E., Wesseling, S., de Sain-van der Velden, M., Koomans, H. A., Braam, B., & Joles, J. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095794 · Cited by 85
Yang, K., Xu, X., Nie, L., Xiao, T., Guan, X., He, T., Yu, Y., Liu, L., Huang, Y., Zhang, J., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.01.021 · Cited by 91
Chandramohan, G., Bai, Y., Norris, K. C., Rodríguez‐Iturbe, B., & Vaziri, N. D. (2007) · American Journal of Nephrology · doi:10.1159/000110021 · Cited by 91
“provide compelling evidence for upregulation of the intrarenal RAS in this model. Upregulation of the intrarenal RAS in SSR was compounded by an impaired ability to suppress PRA in response to the high-salt diet. In an earlier study, Campbell et al. [ , ,”
BackgroundSelf-citationJohnson, R. J., Gaucher, E. A., Sautin, Y. Y., Henderson, G. N., Angerhofer, A., & Benner, S. A. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.01.017 · Cited by 90
“In turn, oxidative stress has been shown to raise blood pressure[56].”
BackgroundTsai, P., Ka, S., Chao, T., Chang, J., Lin, S., Li, C., Kuo, M.-T., Chen, P., & Chen, A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.029 · Cited by 82
Ali, Q., Wu, Y., & Hussain, T. (2013) · Kidney International · doi:10.1038/ki.2013.193 · Cited by 81
Renal inflammation, autoimmunity and salt‐sensitive hypertension
Rodríguez‐Iturbe, B., Franco, M., Tapia, E., Quiroz, Y., & Johnson, R. J. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05482.x · Cited by 79
Self-citationChronic Exercise Preserves Renal Structure and Hemodynamics in Spontaneously Hypertensive Rats
Agarwal, D., Elks, C. M., Reed, S. D., Mariappan, N., Majid, D. S. A., & Francis, J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3967 · Cited by 82
“Conversely, hypertension has been shown to cause oxidative stress in the kidney (51).”
Franco, M., Tapia, E., Bautista, R., Pacheco, U., Santamaría, J., Quiroz, Y., Johnson, R. J., & Rodríguez‐Iturbe, B. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00463.2012 · Cited by 79
Self-citationInflammation and hypertension: Underlying mechanisms and emerging understandings
Aboukhater, D., Morad, B., Nasrallah, N., Nasser, S. A., Sahebkar, A., Kobeissy, F. H., Boudaka, A., & Eid, A. H. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31019 · Cited by 85
Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases
Casals, G., Perramón, M., Casals, E., Portolés, I., Fernández‐Varo, G., Morales‐Ruiz, M., Puntes, V., & Jiménez, W. (2021) · Antioxidants · doi:10.3390/antiox10050660 · Cited by 81
Zhou, N., Zhao, Y., Yao, Y., Wu, N., Xu, M., Du, H., Wu, J., & Tu, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04742 · Cited by 80
Sărăcilă, M., Panaite, T. D., Papuc, C. P., & CRISTE, R. D. (2021) · Antioxidants · doi:10.3390/antiox10050686 · Cited by 87
“one that begins first, then oxidative stress will appear as a consequence that will further exacerbate the inflammation [72].”
BackgroundFarah, B. Q., Rodrigues, S. L. C., da Silva, G. O., Pedrosa, R. P., Correia, M. D. A., de Barros, M. V. G., Deminice, R., Marinello, P. C., Smart, N. A., Vianna, L. C., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00961 · Cited by 78
Ryan, M. J. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90864.2008 · Cited by 73
“For example, cytokines promote renal vascular endothelial dysfunction (121), development of ANG II hypertension, production of ET-1 (84), generation of oxidative stress (138), and progression of insulin resistance (18, 140).”
Background
Metadata
- Authors
- Vaziri, N. D., & Rodríguez-Iturbe, B.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Vaziri, Nosratola D
- ORCID
- Vaziri, Nosratola D
- Venue
- Nature Clinical Practice Nephrology
- Published
- 2006-10
- Volume
- 2
- Issue
- 10
- Pages
- 582-593
- ISSN
- 1745-8323 (ISSN-L)
- 1745-8331
- OpenAlex
- W1990296073
- Cited by
- 442
- References
- 127
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 23 · 2023: 12 · 2022: 31 · 2021: 34 · 2020: 33 · 2019: 20 · 2018: 22 · 2017: 23 · 2016: 17 · 2015: 18 · 2014: 18 · 2013: 22 · 2012: 25
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- hypertension pathogenesis, oxidative stress, inflammation, reactive oxygen species, antioxidants, cytokines, malignant hypertension, accelerated hypertension, salt-sensitive hypertension, target organ damage, cardiovascular disease, renal complications
- MeSH terms
- Animals, Humans, Hypertension, Inflammation, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.